Gabriel Vivó-Truyols from the Spanish Council for Scientific Research, Madrid, Spain. discusses his work on using graph theory and Bayesian statistics for peak assignment and chromatographic alignment.
|Articles|January 12, 2022
- January 2022
- Volume 18
- Issue 1
Vol 18 No 1 The Column January 2022 North American PDF
Click the link above to open The Column January 2022 North American issue, Volume 18, Number 1, in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
Rising Stars of Separation Science: Hedvika Raabováalmost 5 years ago
Critical Evaluation of Chromatography Methods—Essential Detective Skillsalmost 5 years ago
Thermo Fisher Finalizes PPD Acquisitionalmost 5 years ago
Gerstel Group Changes Ownershipalmost 5 years ago
Novasep Invests €6 Million into Chasse-sur-Rhône Sitealmost 5 years ago
Vol 18 No 1 The Column January 2022 Europe & Asia PDFAdvertisement
Related to this article
Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
How can advanced separations, inert hardware, orthogonal methods, and AI solve key challenges in reliable GLP-1 peptide analysis workflows?
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Advertisement
Advertisement
Trending on LCGC International
1
LC–MS/MS Dried Blood Spot Test for Galactosemia
2
GLP-1 Peptide Analysis: Challenges and Solutions
3
AI/ML Now: Uncertainty-Driven Model-Based Search Methods for Method Development in Liquid Chromatography (Part One)
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5